Reducing Sedentary Time for Leukemia
(ReSeT in ALL Trial)
Trial Summary
What is the purpose of this trial?
The goal of this pilot clinical trial is to test if a mobile health intervention, including a wearable fitness tracker with inactivity-triggered reminders to move, individualized coaching sessions, and an app-based peer support group, can decrease sedentary time (time spent sitting/lying down and inactive) in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy. The main questions it aims to answer are: * Is the intervention a feasible and acceptable way to decrease sedentary time among adolescents and young adults (AYAs) with ALL? * Does the intervention show evidence that it may decrease sedentary time? * Does the intervention show evidence that it may increase quality of life, reduce inflammation, and improve glucose and lipid metabolism? Participants will use their fitness tracker with reminders to move as well as support from other intervention participants and coaching with study staff to gradually decrease their sedentary time over 10 weeks. Researchers will compare participant pre- and post-intervention study measures to see if the program may be helpful to decrease sedentary time in adolescents and young adults (AYAs) with ALL. All participants will wear an activity tracker on the thigh for 7 days at the beginning and end of the study as well as complete quality of life questionnaires. Study labs will be collected three times (baseline, 8 weeks, and 12 weeks) over the course of the 12-week study. All in-person study visits and labs will occur in conjunction with Oncology clinic visits for maintenance chemotherapy.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. It focuses on reducing sedentary time for those receiving maintenance chemotherapy.
What data supports the effectiveness of the treatment for reducing sedentary time in leukemia patients?
Research suggests that reducing sedentary behavior can improve health outcomes for cancer patients, and using wearable activity trackers has shown positive effects on physical activity and health in children with cancer. These findings indicate that similar interventions may help leukemia patients by encouraging more movement and reducing time spent sitting.12345
Is reducing sedentary time safe for people with leukemia?
How is the sedentary time intervention treatment for leukemia different from other treatments?
The sedentary time intervention for leukemia is unique because it focuses on reducing the time spent sitting or lying down, using tools like wearable fitness trackers and mobile health technology. Unlike traditional treatments that may focus on medication or chemotherapy, this approach aims to improve health by encouraging more movement and less sedentary behavior, which is a novel strategy for managing leukemia.68101112
Research Team
Brittany J Van Remortel, MD, MPH
Principal Investigator
Children's Hospital Los Angeles
Eligibility Criteria
This trial is for adolescents aged 12-18 with acute lymphoblastic leukemia who are sedentary, spending on average 8+ hours a day sitting or lying down. They must have completed at least one cycle of maintenance chemotherapy and be willing to reduce their sedentary time. Participants need internet access, a smartphone compatible with Fitbit and WhatsApp, and speak English fluently.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a multi-component mobile health intervention including a wearable fitness tracker, individualized coaching sessions, and an app-based peer support group to decrease sedentary time over 10 weeks.
Follow-up
Participants are monitored for changes in sedentary time, quality of life, and metabolic markers post-intervention.
Treatment Details
Interventions
- Sedentary time intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Los Angeles
Lead Sponsor